Biobijou Co. Ltd. (489460) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biobijou Co. Ltd. (489460:KRX), powered by AI.
- Current Price
- ₩6,810
- P/E Ratio
- 24.7
- Market Cap
- 102.5B
- Sector
- Healthcare
What is the Biobijou Co. Ltd. stock price forecast?
Biobijou Co. Ltd. is currently trading at ₩6,810. View real-time AI analysis on Alpha Lenz.
What is Biobijou Co. Ltd. insider trading activity?
View the latest insider trading data for Biobijou Co. Ltd. on Alpha Lenz.
What is Biobijou Co. Ltd.'s P/E ratio?
Biobijou Co. Ltd.'s P/E ratio is 24.7.
Biobijou Co. Ltd.
KRX · 489460“Biobijou Co. Ltd. trades at a P/E of 24.7 (fair value) with solid ROE of 8.9%. 3Y revenue CAGR of 10.6% highlights clear growth momentum.”
Ask for details →Company Overview
Biobijou Co. Ltd. is a South Korean company specializing in the production and global distribution of medical aesthetic products, with a primary emphasis on professional-grade solutions. Since its establishment in 2018, the company has focused on developing advanced hyaluronic acid dermal fillers, skin boosters, fat-dissolving products, and botulinum toxin formulations for use in the medical beauty industry. Biobijou is recognized for its CE-marked products, ensuring compliance with stringent international standards. The company positions itself as a leader in the K-beauty sector, striving to enhance health and beauty with innovative, technology-driven products. Its offerings cater to both domestic and international markets, with a substantial portion of revenue derived from exports. With a commitment to research, quality, and customer service, Biobijou Co. Ltd. plays a significant role in advancing the medical beauty and aesthetics landscape, contributing to the global reputation of South Korea as a hub for cosmetic innovation.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Biobijou Co. Ltd. trades at a P/E of 24.7 (fair value) with solid ROE of 8.9%. 3Y revenue CAGR of 10.6% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
Biobijou Co. Ltd. (ticker: 489460) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). Market cap is $102.5B.
The current price is ₩6,810 with a P/E ratio of 24.68x and P/B of 1.65x.
ROE is 8.94% and operating margin is 14.84%. Annual revenue is $28.5B.